• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDPLAST MEDICAL, INC. REZUM; UNIT, ELECTROSURGICAL ENDOSCOPIC (WITH OR WITHOUT ACCESSORIES)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDPLAST MEDICAL, INC. REZUM; UNIT, ELECTROSURGICAL ENDOSCOPIC (WITH OR WITHOUT ACCESSORIES) Back to Search Results
Model Number D2201
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Muscle Spasm(s) (1966); Urinary Retention (2119)
Event Date 07/17/2019
Event Type  Injury  
Event Description
The patient underwent the study procedure and was given a prostate block, epidural, anti-anxiety and pain medication.During procedure a total of 15 treatments were performed.No device observations or adverse events occurred during treatment.The same day post procedure, the patient experienced bladder spasms for which myrbetriq (dose unknown) was administered.The bladder spasm resolved 7 days post onset symptoms.At 7 days post the index procedure, the patient started experiencing urinary retention for which catherization was performed.The urinary retention resolved 20 days post onset symptom.The investigator assessment of the patient symptom of bladder spasms and urinary retention were assessed as definitely related to the procedure and not related to the device.The clinical end point committee (cec) adjudicated the patient bladder spasm and urinary retention as definite treatment related.The cec adjudicated the bladder spasm as possible device related and unlikely device related for the urinary retention.
 
Event Description
The patient underwent the study procedure and was given a prostate block, epidural, anti-anxiety and pain medication.During procedure a total of 15 treatments were performed.No device observations or adverse events occurred during treatment.The same day post procedure, the patient experienced bladder spasms for which myrbetriq (dose unknown) was administered.The bladder spasm resolved 7 days post onset symptoms.At 7 days post the index procedure, the patient started experiencing urinary retention for which craterization was performed.The urinary retention resolved 20 days post onset symptom.The investigator assessment of the patient symptom of bladder spasms and urinary retention were assessed as definitely related to the procedure and not related to the device.The clinical end point committee (cec) adjudicated the patient bladder spasm and urinary retention as definite treatment related.The cec adjudicated the bladder spasm as possible device related and unlikely device related for the urinary retention.
 
Manufacturer Narrative
The device history record (dhr) confirmed that the devices met all material, assembly and performance specifications.The device is not available for analysis.A review of the device ifu and operators manual was completed and did not reveal any evidence of device misuse, off-label use, or failure to follow instructions.The potential cause and controls for complaints related to clinical events were identified.Based on the information currently available an evaluation conclusion code of known inherent risk of the device was assigned to this investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REZUM
Type of Device
UNIT, ELECTROSURGICAL ENDOSCOPIC (WITH OR WITHOUT ACCESSORIES)
Manufacturer (Section D)
MEDPLAST MEDICAL, INC.
5079 33rd street se
grand rapids MI 49512
MDR Report Key9282226
MDR Text Key165246568
Report Number2937094-2019-61479
Device Sequence Number1
Product Code KNS
Combination Product (y/n)N
PMA/PMN Number
K180237
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type study,user facility
Type of Report Initial,Followup
Report Date 02/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/05/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/26/2021
Device Model NumberD2201
Device Catalogue NumberD2201
Device Lot Number2019020247
Was Device Available for Evaluation? No
Date Manufacturer Received02/04/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age72 YR
-
-